Melissa Epperly - 02 Oct 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Chief Financial Officer
Signature
By: /s/ Melissa B. Epperly
Issuer symbol
ZNTL
Transactions as of
02 Oct 2021
Transactions value $
-$1,146,580
Form type
4
Filing time
04 Oct 2021, 21:16:35 UTC
Previous filing
20 Aug 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Tax liability -$1,146,580 -17,080 -6.4% $67.13 250,002 02 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 397 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on September 30, 2021.